Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03723265 · ClinicalTrials.gov registry record

Personalized CRT - PSR

A clinical trial of Heart Failure, sponsored by Medtronic.

Completed
Registry status
1,517
Enrollment target
20
Study locations

NCT03723265 is a study of Heart Failure that has completed, run by Medtronic. The registered enrollment target is 1,517 participants, below the 2,045-participant average among 397 other Heart Failure trials with a reported enrollment target (26% lower). The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03723265, a study of Heart Failure, has completed, sponsored by Medtronic.

COMPLETED
Registry status
1,517 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the cardiac resynchronization therapy (CRT) response in a real-world patient population and evaluate options to address non-response and patient management.

Conditions Studied

Interventions

  • DEVICE Cardiac Resynchronization Therapy

Study Locations (20)

California

  • - Bakersfield
  • - Chula Vista
  • - Palm Springs
  • - Rancho Mirage
  • - Redwood City
  • - Salinas
  • - San Diego
  • - Stanford
  • - Torrance
  • - Van Nuys

Arkansas

  • - Jonesboro
  • - Little Rock

Colorado

  • - Denver
  • - Lakewood

Alabama

  • - Birmingham

Alaska

  • - Anchorage

Arizona

  • - Gilbert

Connecticut

  • - New Haven

District of Columbia

  • - Washington D.C.

Trial Details

FieldValue
Enrollment Target 1,517 participants
Start Date 2012-01
Est. Completion 2022-04-28

Sponsor

Medtronic

30 total trials

What the Registry Record Tells You About NCT03723265

The ClinicalTrials.gov registry entry for NCT03723265 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,517 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,045-participant average among 397 other Heart Failure trials with a reported enrollment target (26% lower). The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Cardiac Resynchronization Therapy is the first listed.

NCT03723265 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, Arkansas, Colorado.

Frequently Asked Questions

What is clinical trial NCT03723265 about?

NCT03723265 is a clinical study titled "Personalized CRT - PSR". The purpose of this study is to evaluate the cardiac resynchronization therapy (CRT) response in a real-world patient population and evaluate options to address non-response and patient management.

What is the current status of trial NCT03723265?

This trial is currently completed. The enrollment target is 1,517 participants. The study started on 2012-01. Estimated completion is 2022-04-28.

What conditions does trial NCT03723265 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT03723265?

The interventions under investigation include: Cardiac Resynchronization Therapy (DEVICE).

Who is sponsoring clinical trial NCT03723265?

This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03723265 being conducted?

This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.